A comparative study of collagenase complex and new homogeneous collagenase preparations for scar treatment
Journal of Drug Delivery Science and Technology, ISSN: 1773-2247, Vol: 16, Issue: 4, Page: 285-292
2006
- 20Citations
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Abstract Description
The unique feature of collagenase is the ability to cleave the native triple helix of intact collagen molecules. This ability makes it particularly effective in the removal of detritus but not in scar treatment. Three crude collagenase preparations containing Cl. histolyticum collagenase, collagenases PC from the hepatopancreas Paralithodes camtshatica and collagenase D from larvae Dermestes frischii were observed as potential drugs for scar treatment. Activity of collagenase D is significantly superior to that of king crab collagenase PC. The observed effect is superior to that of Cl. histolyticum collagenase. It was established that collagenase D may be used for treatment of keloids and hypertrophic scars. Liniment Morikrol containing collagenase PC was effectively applied for scar treatment and in other cases where skin may regenerate.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1773224706500528; http://dx.doi.org/10.1016/s1773-2247(06)50052-8; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33748644930&origin=inward; http://linkinghub.elsevier.com/retrieve/pii/S1773224706500528; http://api.elsevier.com/content/article/PII:S1773224706500528?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1773224706500528?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1773224706500528; http://dx.doi.org/10.1016/s1773-2247%2806%2950052-8; https://dx.doi.org/10.1016/s1773-2247%2806%2950052-8
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know